Mao Qiang Wang1, Yan Wang2, Jie Yu Yan2, Kai Yuan2, Guo Dong Zhang2, Feng Duan2, Kai Li2. 1. Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China. wangmq@vip.sina.com. 2. Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
Abstract
PURPOSE: To compare the safety and efficacy of PAE for the treatment of benign prostatic hyperplasia (BPH) in men ≥75 years, who we defined as elderly, to those <75 years. METHODS: A total of 157 patients diagnosed with lower urinary tract symptoms (LUTS) due to BPH underwent PAE. Group A (n = 52) included patients ≥75 years, and group B (n = 105) included patients <75 years. Follow-up was performed using the International Prostate Symptoms Score (IPSS), quality of life (QoL), peak urinary flow rate (Q max), post-void residual volume (PVR), the International Index of Erectile Function short form (IIEF-5), prostatic-specific antigen (PSA), and prostate volume (PV), at 1, 3, 6, and every 6 months thereafter. RESULTS: More coexistent systemic diseases were identified in group A than in group B (P < 0.05). Technical success rate of PAE was 90.4 % in group A and 95.2 % in group B (P = 0.06). A total of 147 patients had completed the follow-up with a mean of 20 months. Compared with the baseline, there were significant improvements in IPSS, QoL, Q max, PV, PVR, and PSA in both groups after PAE. There were no significant differences in the changes of IPSS, Q max, PVR, PSA, and IIEF-5 between groups after PAE. No major complications were noted. CONCLUSION: PAE could be used as an effective, safe, and well tolerable method in the treatment of elderly symptomatic BPH patients, similarly to younger patients, and it may play an important role in patients in whom medical therapy has failed, who are at high surgical and anesthetic risk or who refuse the standard surgical therapy.
PURPOSE: To compare the safety and efficacy of PAE for the treatment of benign prostatic hyperplasia (BPH) in men ≥75 years, who we defined as elderly, to those <75 years. METHODS: A total of 157 patients diagnosed with lower urinary tract symptoms (LUTS) due to BPH underwent PAE. Group A (n = 52) included patients ≥75 years, and group B (n = 105) included patients <75 years. Follow-up was performed using the International Prostate Symptoms Score (IPSS), quality of life (QoL), peak urinary flow rate (Q max), post-void residual volume (PVR), the International Index of Erectile Function short form (IIEF-5), prostatic-specific antigen (PSA), and prostate volume (PV), at 1, 3, 6, and every 6 months thereafter. RESULTS: More coexistent systemic diseases were identified in group A than in group B (P < 0.05). Technical success rate of PAE was 90.4 % in group A and 95.2 % in group B (P = 0.06). A total of 147 patients had completed the follow-up with a mean of 20 months. Compared with the baseline, there were significant improvements in IPSS, QoL, Q max, PV, PVR, and PSA in both groups after PAE. There were no significant differences in the changes of IPSS, Q max, PVR, PSA, and IIEF-5 between groups after PAE. No major complications were noted. CONCLUSION:PAE could be used as an effective, safe, and well tolerable method in the treatment of elderly symptomatic BPH patients, similarly to younger patients, and it may play an important role in patients in whom medical therapy has failed, who are at high surgical and anesthetic risk or who refuse the standard surgical therapy.
Authors: Sandeep Bagla; Cynthia P Martin; Arletta van Breda; Michael J Sheridan; Keith M Sterling; Dimitrios Papadouris; Kenneth S Rholl; John B Smirniotopoulos; Arina van Breda Journal: J Vasc Interv Radiol Date: 2013-10-28 Impact factor: 3.464
Authors: Justin P McWilliams; Michael D Kuo; Steven C Rose; Sandeep Bagla; Drew M Caplin; Emil I Cohen; Salomao Faintuch; James B Spies; Wael E Saad; Boris Nikolic Journal: J Vasc Interv Radiol Date: 2014-06-30 Impact factor: 3.464
Authors: Tiago Bilhim; João Pisco; Hugo Rio Tinto; Lúcia Fernandes; Luís Campos Pinheiro; Marisa Duarte; José A Pereira; António G Oliveira; João O'Neill Journal: Cardiovasc Intervent Radiol Date: 2012-12-12 Impact factor: 2.740
Authors: Mao Qiang Wang; Li Ping Guo; Guo Dong Zhang; Kai Yuan; Kai Li; Feng Duan; Jie Yu Yan; Yan Wang; Hai Yan Kang; Zhi Jun Wang Journal: BMC Urol Date: 2015-04-16 Impact factor: 2.264